ATIR101 + T-cell depleted HSCT from a related, haploidentical donor
2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| ATIR101 + T-cell depleted HSCT from a related, haploidentical donor for graft vs host disease | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| ATIR101 + T-cell depleted HSCT from a related, haploidentical donor for myelodysplastic syndromes | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |